Literature DB >> 17328046

Expected value of sample information for Weibull survival data.

Alan Brennan1, Samer A Kharroubi.   

Abstract

Expected value of sample information (EVSI) involves simulating data collection, Bayesian updating, and re-examining decisions. Bayesian updating in Weibull models typically requires Markov chain Monte Carlo (MCMC). We examine five methods for calculating posterior expected net benefits: two heuristic methods (data lumping and pseudo-normal); two Bayesian approximation methods (Tierney & Kadane, Brennan & Kharroubi); and the gold standard MCMC. A case study computes EVSI for 25 study options. We compare accuracy, computation time and trade-offs of EVSI versus study costs. Brennan & Kharroubi (B&K) approximates expected net benefits to within +/-1% of MCMC. Other methods, data lumping (+54%), pseudo-normal (-5%) and Tierney & Kadane (+11%) are less accurate. B&K also produces the most accurate EVSI approximation. Pseudo-normal is also reasonably accurate, whilst Tierney & Kadane consistently underestimates and data lumping exhibits large variance. B&K computation is 12 times faster than the MCMC method in our case study. Though not always faster, B&K provides most computational efficiency when net benefits require appreciable computation time and when many MCMC samples are needed. The methods enable EVSI computation for economic models with Weibull survival parameters. The approach can generalize to complex multi-state models and to survival analyses using other smooth parametric distributions. (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17328046     DOI: 10.1002/hec.1217

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  7 in total

1.  Value of information and pricing new healthcare interventions.

Authors:  Andrew R Willan; Simon Eckermann
Journal:  Pharmacoeconomics       Date:  2012-06-01       Impact factor: 4.981

2.  Exploring uncertainty in cost-effectiveness analysis.

Authors:  Karl Claxton
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

3.  Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling.

Authors:  Hawre Jalal; Jeremy D Goldhaber-Fiebert; Karen M Kuntz
Journal:  Med Decis Making       Date:  2015-04-03       Impact factor: 2.583

Review 4.  A systematic and critical review of the evolving methods and applications of value of information in academia and practice.

Authors:  Lotte Steuten; Gijs van de Wetering; Karin Groothuis-Oudshoorn; Valesca Retèl
Journal:  Pharmacoeconomics       Date:  2013-01       Impact factor: 4.981

5.  Value of Information Analysis in Models to Inform Health Policy.

Authors:  Christopher H Jackson; Gianluca Baio; Anna Heath; Mark Strong; Nicky J Welton; Edward C F Wilson
Journal:  Annu Rev Stat Appl       Date:  2022-03-07       Impact factor: 7.917

6.  Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies.

Authors:  Anna Heath; Natalia Kunst; Christopher Jackson; Mark Strong; Fernando Alarid-Escudero; Jeremy D Goldhaber-Fiebert; Gianluca Baio; Nicolas A Menzies; Hawre Jalal
Journal:  Med Decis Making       Date:  2020-04-16       Impact factor: 2.583

7.  Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample: A Fast, Nonparametric Regression-Based Method.

Authors:  Mark Strong; Jeremy E Oakley; Alan Brennan; Penny Breeze
Journal:  Med Decis Making       Date:  2015-03-25       Impact factor: 2.583

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.